AbbVie amends bylaws, deletes section 2.13(D)(iv) amid stockholder class action

AbbVie Inc.

Board approved Third Amended and Restated By-laws effective September 6, 2024.
Amendments update registered agent address and delete Section 2.13(D)(iv) in its entirety.
Company is defendant in a stockholder class action challenging Section 2.13(D)(iv).
Company believes provision lawful but no longer of practical value; deletion avoids defending it.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.